Phase 2 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Stargardt disease caused by a change (mutation) in a gene called ABCA4, confirmed through genetic testing
- People who are willing to follow all the study requirements and give their informed consent
Who may not be able to join:
- People who are unwilling or unable to meet the requirements of the study
- People who are currently taking part in another clinical trial involving an investigational (not yet approved) medicine
- People who have previously taken part in a gene therapy or cell therapy trial
- People who have a health condition that would make a type of eye surgery called subretinal surgery unsafe or unsuitable for them (confirm with trial site)
- People who have other significant eye conditions or other serious health conditions that could interfere with the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +448000465680
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To measure the number and severity of treatment related adverse events following treatment with AAVB-039
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.